MoMoGains| Next 10 |
Now Trending
Trending Stock
28.26%Change Percent:
Alimera Sciences Inc. Company Name:
ALIM Stock Symbol:
NASDAQ Market:
alimerasciences.com Website:
MENU
ALIM Stock
ALIM Quote
ALIM Short
ALIM News
ALIM Articles
ALIM Message Board
Get ALIM Stock Alerts
News, Short Squeeze, Breakout and More Instantly...
RECENT ALIM NEWS
-
ATLANTA, Nov. 13, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces that it has terminated its $20.0 mill...
-
In a bid to regain compliance with the minimum bid price requirement, Alimera Sciences (NASDAQ: ALIM ) announced a one-for-15 reverse stock split of its common stock, effective after the close on Nov. 14. More news on: Alimera Sciences, Inc., Healthcare stocks news, Rea...
-
ATLANTA, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces that it will effect a one-for-15 reverse s...
ACCESSWIRE IA News Releases and Press Releases
ACCESSWIRE IA news releases, related news releases, and press releases on the OTC, NASDAQ and NYSE markets.
-
NEW YORK, NY / ACCESSWIRE / November 13, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide ...
-
NEW YORK, NY / ACCESSWIRE / November 13, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide ...
-
NEW YORK, NY / ACCESSWIRE / November 13, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide ...
-
NEW YORK, NY / ACCESSWIRE / November 13, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide ...
-
NEW YORK, NY / ACCESSWIRE / November 13, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide ...
-
NEW YORK, NY / ACCESSWIRE / November 13, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide ...
-
NEW YORK, NY / ACCESSWIRE / November 13, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide ...
-
NEW YORK, NY / ACCESSWIRE / November 13, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide ...
-
NEW YORK, NY / ACCESSWIRE / November 13, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide ...
-
NEW YORK, NY / ACCESSWIRE / November 13, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide ...
x
